198 related articles for article (PubMed ID: 16131568)
1. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas.
Bechtel D; Kurth J; Unkel C; Küppers R
Blood; 2005 Dec; 106(13):4345-50. PubMed ID: 16131568
[TBL] [Abstract][Full Text] [Related]
2. Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.
Mancao C; Altmann M; Jungnickel B; Hammerschmidt W
Blood; 2005 Dec; 106(13):4339-44. PubMed ID: 16076866
[TBL] [Abstract][Full Text] [Related]
3. EBV transformation overrides gene expression patterns of B cell differentiation stages.
Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes.
Chaganti S; Bell AI; Pastor NB; Milner AE; Drayson M; Gordon J; Rickinson AB
Blood; 2005 Dec; 106(13):4249-52. PubMed ID: 16123211
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.
Leonard S; Wei W; Anderton J; Vockerodt M; Rowe M; Murray PG; Woodman CB
J Virol; 2011 Sep; 85(18):9568-77. PubMed ID: 21752916
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
Kurth J; Hansmann ML; Rajewsky K; Küppers R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.
Bräuninger A; Schmitz R; Bechtel D; Renné C; Hansmann ML; Küppers R
Int J Cancer; 2006 Apr; 118(8):1853-61. PubMed ID: 16385563
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center.
Tinguely M; Rosenquist R; Sundström C; Amini RM; Küppers R; Hansmann ML; Bräuninger A
Am J Surg Pathol; 2003 Nov; 27(11):1483-8. PubMed ID: 14576485
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.
Portis T; Dyck P; Longnecker R
Blood; 2003 Dec; 102(12):4166-78. PubMed ID: 12907455
[TBL] [Abstract][Full Text] [Related]
11. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and the B cell: a secret romance.
Schuster VH; Müschen M
Trends Microbiol; 2003 Jun; 11(6):243-5. PubMed ID: 12823936
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
14. Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma.
Rosenquist R; Menestrina F; Lestani M; Küppers R; Hansmann ML; Bräuninger A
Lab Invest; 2004 Feb; 84(2):253-62. PubMed ID: 14688797
[TBL] [Abstract][Full Text] [Related]
15. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
Timms JM; Bell A; Flavell JR; Murray PG; Rickinson AB; Traverse-Glehen A; Berger F; Delecluse HJ
Lancet; 2003 Jan; 361(9353):217-23. PubMed ID: 12547545
[TBL] [Abstract][Full Text] [Related]
16. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and pathologic features of Hodgkin lymphoma.
Nakatsuka S; Aozasa K
Int J Hematol; 2006 Jun; 83(5):391-7. PubMed ID: 16787868
[TBL] [Abstract][Full Text] [Related]
18. Somatic hypermutation and B cell receptor selection in normal and transformed human B cells.
Küppers R
Ann N Y Acad Sci; 2003 Apr; 987():173-9. PubMed ID: 12727637
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma.
Mohamed G; Vrzalikova K; Cader FZ; Vockerodt M; Nagy E; Flodr P; Yap LF; Diepstra A; Kluin PM; Rosati S; Murray P
J Gen Virol; 2014 Sep; 95(Pt 9):1861-1869. PubMed ID: 24893782
[TBL] [Abstract][Full Text] [Related]
20. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
